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Abstract 
BACKGROUND: Fatigue and depression affect the illness perception of patients with multiple sclerosis (MS). The 
purpose of the present study was to investigate the role of fatigue and depression in illness perception of patients 
with MS. 
METHODS: The present study was a descriptive correlational research. The target population was all patients with 
MS who referred to the Iranian MS Society. The sample consisted of 138 patients who were selected using 
convenience sampling. Data were gathered using the Fatigue Severity Scale (FSS), Beck Depression Inventory 
(BDI), and Brief Illness Perception Questionnaire (Brief IPQ) and were analyzed via stepwise regression analysis 
and Pearson's correlation coefficient. 
RESULTS: Based on study findings, fatigue and depression had a statistically significant relationship with all 
subscales of illness perception. The results of stepwise regression analysis indicated that fatigue and depression 
predict disease outcome, personal control, therapeutic‎ control, identity, concern, illness recognition, and emotion 
regulation among patients with MS. 
CONCLUSION: The findings of this research showed that illness perception, as an effective indicator in patient's 
quality of life (QOL), appears to be predicted by fatigue and depression. 
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Introduction1 
Multiple sclerosis (MS) is a chronic,1 
demyelinating,2 autoimmune,3 and progressive 
disease in the central nervous system (CNS).4 
The disease affects the brain and spinal cord, 
and affects with a range of potential disabling 
symptoms, including changes in feelings, 
vision problems, muscle weakness, depression, 
and problem in coordination and speaking, 




severe fatigue, cognitive impairment, balance 
problems, and pain.5,6 MS often affects the 
young population of societies and causes 
disability among these patients;1 thus, it has 
received a great deal of scientific attention. The 
goal of most scientific and practical 
developments in this area is to provide 
conditions that do not decrease the quality of 
life (QOL) of patients to the extent possible 
and cause the least harm to the patient's family 
and society.7 
Therefore, the determination of factors 
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necessary. Various studies of variables such as 
personality traits,8 disability,9 cognitive 
impairment,10 and perception of the disease 
had great impact on the QOL of these 
patients.11 Considering the existing gap in the 
research and the significance of the perception 
of disease, the present study addressed the 
factors associated with the perception of 
disease in patients with MS. The importance of 
this topic is due to the fact that the perception 
of disease as a threatening factor can lead to 
adverse outcomes and reduce the QOL of these 
patients.12 In fact, this structure affects social 
psychological and family structures, and the 
implications of research on QOL-related 
issues, which are closely related to anxiety, 
depression, and physical functioning, and 
psychology of the relationship.11 In patients 
with MS, the lack of effective control, 
complications, and clear efficacy results can 
affect their perceptions of their disease.13 
Considering that the perception of the 
illness in the members of the community is 
affected by the problems affecting the whole 
community, tools with high consistency 
should be use and the effectiveness of their 
implementation, that can be customized and 
improved, should be assessed. The 
examination of this structure is an important 
requirement in patients with MS.14 The most 
widely applied model for explaining the 
relationship between illness perceptions and 
emotional and behavioral responses is the self-
regulatory model.15  
The theoretical basis of the present study 
was the Leventhal self-regulation theory, 
which focuses specifically on the role of 
disease perception and experiences of 
symptoms, and is based on the nature of the 
patient, duration of illness, and 
therapeutic ‎control. Based on this model, the 
evaluation of illness is based on the assessment 
of the impact and effective deployment of a 
comprehensive set of related behaviors, 
followed by monitoring activities.13 Moreover, 
this model emphasizes that some stimuli, 
including physical symptoms and existing 
health beliefs, provide emotional and cognitive 
representations of disease.16  
In general, the Leventhal self-regulation 
model as an appropriate model examines the 
role of disease perception and emotional 
responses in chronic diseases.17 In this regard, 
research evidence suggests that the subscales 
of this structure, i.e., the nature and timing of 
responses, are the major predictors of positive 
recognition in the residents. In contrast, 
cognitive knowledge and personal control are 
very important in psychological disorders.18 
Some research findings suggest that the 
workforce needs to be integrated into the 
implementation of a global approach and work 
to reduce anxiety.19 In fact, the perception of 
disease is correlated with anxiety.20  
On the other hand, the perception of disease 
adversely reduces the therapeutic follow-up in 
individuals with chronic illness and increases 
depression in these patients.14 The literature 
shows that mood disorders are common in 
patients with MS and depression is the most 
common of these disorders. In explaining this 
relationship, it can be stated that the 
development of chronic diseases, such as MS, 
affects the ability to move and work and health 
of patients due to various symptoms,1 and 
increases the risk of the development of 
psychiatric disorders, such as depression.21 The 
incidence of major depression in these patients 
has been estimated at 50% in several studies, 
which is significantly higher than the general 
population and other neurological disorders. 
In addition, suicidal tendencies in these 
patients are largely linked to the presence of 
major depression.22  
Costa et al. showed that symptoms of 
depression are related to the perception of 
disease. In this study, the subscales of 
outcome, nature of illness, disease recognition, 
and anxiety were found to have significant 
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chronic pain.23 Shallcross et al., in a study on 
patients suffering from epilepsy, showed that 
the high prevalence of depression is associated 
with a negative perception and low QOL.24 
Steca et al., in their study on cardiovascular 
disease (CVD), showed that perception of 
disease was associated with depression in 
these patients.25 In their study, price et al. 
showed that subscales of perceived disease 
such as outcome, nature of illness, concern, 
personal control, and emotional response were 
associated with depression in chronic 
diseases.16 Philip et al. in a study on patients 
suffering from lupus, found a significant 
relationship between depression and the 
subscales of outcome, disease control, and 
disease duration.17  
Additionally, perceptions of illness are tied 
to tangible fatigue, as those who are more 
likely to experience fatigue, are expected to 
experience longer disease duration, and 
negative beliefs have many harmful outcomes. 
Moreover, high prevalence of fatigue is 
associated with a disability in personal control 
and a lack of confidence in the therapeutic 
outcome.26 Grayson et al., in a research study, 
showed that the perception of disease has a 
causal role in the survival of patients with 
vasculitis.27 In fact, the most frustrating,28 and 
the most debilitating symptom of MS is 
fatigue, which affects about 75-90% of 
patients.29 Fatigue is often defined as a lack of 
energy, a feeling of exhaustion and general 
weakness. In this regard, the International 
Society for Multiple Sclerosis has defined 
fatigue as a mental or physical lack of energy 
perceived by a person or caretaker that 
interferes with the person's usual activities. 
Fatigue significantly affects QOL and has 
major socioeconomic outcomes such as 
frequent absence from work and subsequent 
loss of employment. It also interferes with the 
daily lives of patients with MS, including their 
private life. Despite the many studies and 
extensive researches, the nature and cause of 
fatigue in these patients have not been 
understood.30 However, some sources suggest 
that this syndrome is caused by 
demyelination.31 
Verified treatments for MS have limited 
effects on fatigue. The reason for this problem 
has not been clearly defined, although various 
pathophysiological mechanisms have been 
considered.30 Therefore, fatigue is one of the 
main causes of disability in patients MS, and 
there is currently no specific treatment for this 
symptom of MS. Depression symptoms such as 
loss of motivation or lack of pleasure can be 
confused with fatigue. Fatigue may be one of 
the symptoms of depression. However, some of 
the causes of fatigue in patients with MS may 
be treatable (for example, depression) and 
finding and recognizing them among these 
people is a challenge since the relationship 
between fatigue and mood disorder in patients 
with MS is unclear.32 Therefore, fatigue and 
depression in the majority of patients with MS 
are known to be the most debilitating 
symptoms. Several studies have shown that 
these symptoms can affect chronic illnesses in 
patients.16 As mentioned above, the present 
study was designed to predict the perception of 
patients with MS suffering from fatigue and 
depression. 
Materials and Methods 
This research was a descriptive and 
correlational study that examined the 
correlation between predictor variables and 
the criterion variable, and the predictive power 
of this correlation. The purpose of this study 
was to investigate the variables of perceived 
disease of patients with MS as criterion 
variables based on the predictors of depression 
and fatigue. The statistical population of this 
study consisted of all patients suffering from 
MS in Iran in 2017, whose were diagnosed by a 
neurologist and had a medical file in this 
regard in Iranian MS Society. Convenience 
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138 individuals participated in the study. The 
inclusion criteria were good reading and 
writing skills and sufficient physical and 
mental fitness to complete the research tools, 
and the exclusion criteria were disease 
duration of less than 1 year, severe cognitive 
impairment, or other chronic diseases.  
In order to observe ethical considerations, 
the participants were entered into the research 
after obtaining informed consent from the 
patients or their relatives and assuring them 
that their personal information would remain 
confidential. Finally, the patients completed 
the research tools under the supervision of one 
of the authors of the study who was present at 
the site of the study.  
Data were analyzed using descriptive 
statistics (mean and standard deviation), and 
non-inferential statistics (Pearson correlation 
coefficient and stepwise regression) in SPSS 
software (version 21, IBM Corporation, 
Armonk, NY, USA). 
Measurement tools 
Fatigue Severity Scale: A fatigue measurement 
tool was developed in 1988 by a neurologist 
named Krupp to measure fatigue in patients 
suffering from MS. This tool is one of the most 
reliable scales for measuring the severity of 
fatigue in patients with MS. This scale consists 
of 9 questions, that 5 question assess the quality 
of fatigue, 3 questions quantify physical and 
mental fatigue that determine the social status 
of a person, and 1 question quantifies the 
severity of fatigue with other MS symptoms. 
The score of each question ranges from 1 to 7; a 
score of 1 means that the person strongly 
opposes the situation and the score of 7 means 
the person fully agrees. A score of 7 shows the 
highest level of fatigue and a score of 1 indicates 
a lack of fatigue. Shahvarughi Farahani et al. 
studied the validity and reliability of the 
Persian version of the Fatigue Severity Scale 
(FSS) among patients with MS in Iran.33 The 
internal consistency of the questionnaire items 
was calculated using Cronbach's alpha 
coefficient and was equal to 0.96, which 
indicates internal consistency of all items.  
Beck Depression Inventory: The Beck 
Depression Inventory (BDI), compiled in 1961, 
is one of the most widely used instruments for 
measuring mental disorders. This 
questionnaire contains 21 questions regarding 
depression symptoms, each of which consists 
of 4 or 5 sections. The items are scored on scale 
ranging from 0 to 3 (0 is the absence of 
symptoms of depression and 3 indicates the 
high severity of the disorder in that aspect). In 
this scale, 2 parts are subjective and 11 are 
cognitive, 2 are attributed to noticeable 
behaviors, 5 to physical symptoms, and 1 to 
internal symptoms, all of which are related to 
the symptoms of major depression. A large 
number of studies have been conducted to 
verify the validity and reliability of the BDI, all 
of which have approved the reliability of this 
test and reported the internal consistency of 
this scale between 0.73 and 0.92. The reliability 
of this questionnaire was reported between 
0.48 and 0.86 according to the type of statistical 
population.34 
Brief Illness Perception Questionnaire: The 
Brief Illness Perception Questionnaire (Brief 
IPQ) consists of 9 questions designed to 
evaluate the emotional and cognitive 
visualization of the disease. The questions 
determine the consequences, duration, 
personal control, therapeutic‎ control, nature of 
illness, concern, and disease recognition along 
with emotional response, and cause of the 
disease. The range of total scores of the first  
8 questions consists of 1 to 10. Question 9 is an 
open-ended question regarding the 3 major 
causes of the disease. In the final analysis, it is 
recommended that each of the subscales be 
analyzed separately. The Brief IPQ consists of 
5 subscales of cognitive responses to the 
disease, including perceived consequences 
(Article 1), duration of illness (Article 2), 
personal control (Article 3), control through 
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symptoms (Article 5). It also has the 2 
subscales of concern about illness (Article 6) 
and emotions (Article 8) which measure 
emotional responses, and 1 subscale 
measuring the ability to understand and 
perceive the disease (Article 7). The final item 
is an open-ended question (Article 9), which 
asks the patient to list the most important 
factors that caused their illness. The reliability 
of each subscale of this questionnaire ranged 
from 0.48 to 0.70. The validity of the personal 
control subscale was approved among patients 
with diabetes. Bagherian et al. provided the 
Persian version of this questionnaire.35 The 
Cronbach's alpha of the Persian version of this 
scale was 0.84 and its correlation coefficient 
was 0.71. In general, the results derived from 
the evaluation of the Persian version of this 
scale showed a good and satisfactory validity 
among other patients. 
Results 
Of the 138 patients with MS participating in 
this study, 94 (68%) were women and 44 (32%) 
men and in the age range of 24-58 years (mean: 
60.35 years). The majority of participants  
(82 patients, 59.4%) were married. In terms of 
education, the majority of people  
(71 individuals, 51.4%) had a diploma; among 
the remaining 51 individuals (37%) 12% had a 
B.A., 7.8% were under diploma, and  
4 individuals (2.9%) had an M.A. 
The disease history was also studied, which 
showed that 77.5% of the people had a history 
of hospitalization and 81.2% had used 
medication. The incidence of the disease varied 
between the ages of 1 to 15 (mean: 26.5 years), 
and in most of the patients, 1 to 5 had passed 
years after diagnosis. Furthermore, 34% of the 
patients were employed and 66% were 
unemployed; however, most patients were 
active between 1 and 4 hours per day.  
The Pearson correlation coefficient and 
stepwise regression analysis were used to 
determine the role of fatigue and depression in 
explaining and predicting the perceptual 
representation of patients with MS. The tests 
have assumptions that were considered before 
the inferential analysis. One of the foregoing is 
the normal distribution of research variables; 
the Shapiro-Wilk test was used to measure the 
fitting of predictive and criterion variables. 
The results of the Shapiro-Wilk test showed 
that the scores of fatigue variables (P < 0.001;  
α = 0.050), depression (P = 0.227; α = 0.050), 
and perception of disease (P < 0.001; α = 0.050) 
do not differ significantly from the normal 
curve, which indicates the normal distribution 
of the research variables.  
The second is the linearity of the 
relationship between the criterion variable and 
a predictive variable when all other predictor 
variables are kept constant. The results of the 
data analysis show that, except for the disease 
duration variable, the relationship between 
predictor variables and other criterion 
variables follows this assumption (P < 0.050).  
Another predictor of regression analysis is 
the lack of correlation between predictive 
variables (linear multiplicity), which was used 
to evaluate the validity or tolerance of the 
variables and the variance inflation factor 
(VIF). The results showed that the degree of 
tolerance was close to 1 and the VIF was less 
than 2. Therefore, by fulfilling the assumptions 
of the Pearson correlation coefficient and 
stepwise regression analysis, it is possible to 
use these tests to investigate the research 
hypotheses.  
Table 1 shows the central indices and the 
variability of the research variables. The 
skewness and elongation of all variables were 
between 1+ and 1, which indicates the normal 
distribution of the variables of the research.  
The correlation matrix of the research 
variables along with their correlation 
coefficients and their significance levels are 
provided in table 2‎. As shown in this table, the 
predictor variables of depression and fatigue had 
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Table 1. Descriptive statistics related to research variables 
Variable Minimum Maximum Mean SD Kurtosis Skewness 
Disease outcome 1 8 4.20 1.66 -0.36 0.11 
Disease duration 1 9 4.70 1.75 -0.13 0.14 
Self-control 1 8 4.59 1.86 -0.58 0.14 
Therapeutic control 1 8 4.55 1.90 -0.61 -0.03 
Nature of disease 1 8 4.62 1.95 -0.76 0.40 
Concern 1 9 4.96 1.86 -0.53 0.60 
Recognizing the disease 1 9 4.64 2.03 -0.71 0.16 
Emotional response 1 9 4.54 1.91 -0.65 0.25 
Depression 15 49 31.53 6.68 -0.30 -0.18 
Fatigue 14 58 37.99 9.24 -0.37 -0.12 
 
variables of personal control, therapeutic control, 
and nature of illness, concern, disease 
recognition, and emotional response. This 
relationship was negative in the variables of 
personal control, therapeutic control, and disease 
recognition.  
The correlation matrix also shows that there is 
no significant relationship between predictive 
variables and disease duration; a summary of the 
step-by-step regression model is presented in 
table 3. The results of stepwise regression 
analysis in predicting the outcomes of the 
disease showed that in the first step, fatigue 
explained the significant (0.04%) variance of the 
outcomes of the disease. Moreover, the results of 
stepwise regression analysis showed that in the 
second step, depression and fatigue totally 
explained 20%, 11%, and 12% of the variance of 
the variables of self-control, therapeutic control, 
and recognizing the disease, respectively. In 
addition, 0.051%, 0.056%, and 0.096% of the 
variance of the variables of personal control, 
nature of illness, concern, and emotional 
responses in the first step were explained only 
by fatigue, respectively. 
Discussion 
Considering the fact that the perception of disease 
has a significant role in the QOL of individuals 
with MS and based on the available theoretical 
and empirical literature on the role of fatigue and 
depression as important correlates of perception 
of disease, these subjects were emphasized in the 
present study. The purpose of this study was to 
investigate the role of fatigue and depression in 
MS. Our results showed that there was a positive 
correlation between depression and some of the 
subscales of perceived disease such as disease 
outcomes, nature of illness, concern, and 
emotional response. 
 
Table 2. Correlation matrix of research variables 
Variables 1 2 3 4 5 6 7 8 9 10 
1.Disease outcome 1          
2.Disease duration 0.19
*
 1         
3.Self-control 0.15 0.05 1        
4.Therapeutic control 0.15 0.02 0.42
**
 1       













 0.14 0.13 0.37
**
 1     
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Table 3. Stepwise regression model and subscales of perception of disease in terms of fatigue  
and depression 
Criterion Variable Step 
Predictor 
Variable 
F P R R
2
 β t P 
Disease outcome 1 Fatigue 6.05 0.015 0.206 0.043 0.206 2.46 0.015 
Self-control 2 Depression 16.84 < 0.001 0.447 0.200 2.740 4.84 < 0.001 
Fatigue 2.470 4.36 < 0.001 
Therapeutic control 2 Depression 8.67 < 0.001 0.338 0.114 1.990 3.33 0.001 
Fatigue 1.770 2.96 0.004 
Nature of disease 1 Fatigue 7.36 0.007 0.227 0.051 0.227 2.71 0.007 
Concern 1 Fatigue 8.00 0.005 0.236 0.056 0.236 2.82 0.005 
Recognizing the disease 2 Depression 9.59 < 0.001 0.353 0.124 1.920 3.24 < 0.001 
Fatigue 1.670 2.81 0.006 
Emotional response 2 Depression 7.20 0.001 0.310 0.096 1.470 2.44 0.016 
Fatigue 1.220 2.03 0.044 
 
Depression was also correlated with some 
other subscales of illness such as personal 
control, therapeutic control, and recognition of 
the disease. However, there was no significant 
relationship between depression and disease 
duration. In the next step, regression analysis 
was applied step-by-step to determine the 
contribution of each variable of fatigue and 
depression in the explanation of the subscale 
of perception of disease. The results of 
regression analysis showed that depression 
significantly predicted the changes in personal 
control, therapeutic‎ control, and recognition of 
the disease in changes in emotional responses. 
In explaining these results, it can be said that 
decrease in depression and fatigue increased 
personal control, and cognitive and 
therapeutic control. Therefore, lower degrees 
of depression and fatigue in individuals with 
MS result in stronger beliefs in patients about 
their own knowledge and control of the 
disease, and more promising treatment 
outcomes. On the other hand, increase in the 
degree of depression and fatigue will 
strengthen patients’ belief that disease affects 
their overall QOL (the outcome of the disease), 
resulting in greater concern and negative 
emotional responses.  
These findings are in line with the 
researches by Costa et al.,23 Steca ‎la‎te. ,25 Price 
et al.,16 and Philip et al.17 In the literature, 
quantitative studies have systematically 
examined the role of fatigue in perception of 
the disease in people with MS. In accordance 
with the findings of Grayson et al.,27 in a study 
on patients suffering from vasculitis, and the 
research by Alsen and Eriksson,26 on patients 
who had suffered an infarction, the results of 
this study showed a positive correlation 
between fatigue and the outcomes of the 
disease, nature of illness, concern, and 
emotional response. 
In addition, fatigue had a significant 
negative relationship with personal control, 
therapeutic control, and recognition of the 
disease. The results of regression analysis 
showed that fatigue alone predicts the variance 
in disease outcome, nature of illness, and 
concern. In explanation, it can be stated that 
with increasing fatigue in patients with MS, 
their QOL is affected and their experience of 
symptoms increases their concern. 
Considering the findings of this study, it can 
be concluded that fatigue and depression are 
two important factors in the perception of 
disease in people with MS. Moreover, in the 
manifestation of most of the behaviors 
associated with the disease in these patients, 
these two constructs are affected. 
Conclusion 
The results of this research can be considered at 
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theoretical level, the findings of the present 
study confirmed the Leventhal self-regulatory 
model for the perception of disease. At the 
applied level, the results of this study can be a 
suitable empirical basis for developing 
comprehensive educational, interventional, and 
therapeutic programs for these patients, which 
should be emphasized psychological factors 
along with physical factors. Pencil-paper 
assessment of disease perception, fatigue, and 
depression, and small sample volume, and 
convenience sampling method are among the 
important limitations of this research which have 
reduced the generalizability of the results. 
Moreover, correlational research method was 
used that does not have credibility and certainty 
as far as experimental research is concerned. 
Therefore, studying the variables of the research 
through self-report and other methods of 
measuring, and performing longitudinal and 
cross-sectional studies with other variables 
related to perception of disease can lead to 
achievable findings. 
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